«In less than a year, our group and others have demonstrated that multiple
vaccine platforms can provide robust protection
against Zika virus challenge in animal models.
The Wistar Institute was awarded a $ 1,494,972 grant by the Bill & Melinda Gates Foundation to advance a DNA - based
vaccine candidate for protection against malarial infection utilizing a synthetic DNA platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Re
vaccine candidate for protection
against malarial infection utilizing a synthetic DNA
platform created in the lab of David B. Weiner, Ph.D., executive vice president, director of the
Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Re
Vaccine & Immunotherapy Center at The Wistar Institute and the W.W. Smith Charitable Trust Professor in Cancer Research.